Skip to content
Article Rich – Lifestyle
Author:
Lexaria Bioscience Corp.
Lexaria Enters a Material Transfer Agreement With PegBio
August 13, 2026
The Oracle Legal Group Guides Small Business Owners Through Bankruptcy Options in Houston
August 6, 2026
Lexaria Announces Effective Date for Reverse Stock Split
July 30, 2026
Lexaria Updates Business Development
July 6, 2026
Lexaria’s Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
June 25, 2026
Lexaria’s Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
June 23, 2026
Lexaria’s Animal Study Examining Next-Generation GLP-1 drugs is Underway
June 9, 2026
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
June 3, 2026
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
May 22, 2026
Lexaria Bioscience Releases Second Episode of Investor Video Series
May 7, 2026
1
2
Next Page
→